• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏再同步治疗患者右心室收缩压峰值与主要不良事件的关系。

Relation of right ventricular peak systolic pressure to major adverse events in patients undergoing cardiac resynchronization therapy.

作者信息

Tedrow Usha B, Kramer Daniel B, Stevenson Lynne W, Stevenson William G, Baughman Kenneth L, Epstein Laurence M, Lewis Eldrin F

机构信息

Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.

出版信息

Am J Cardiol. 2006 Jun 15;97(12):1737-40. doi: 10.1016/j.amjcard.2006.01.033. Epub 2006 Apr 24.

DOI:10.1016/j.amjcard.2006.01.033
PMID:16765124
Abstract

The degree to which increased right-sided heart pressures influence outcome in cardiac resynchronization therapy (CRT) is unclear. High right ventricular (RV) pressures may contribute to septal malpositioning, thus hindering effective resynchronization. We hypothesized that patients with high RV systolic pressures before CRT implantation would have poorer outcome. We evaluated echocardiograms, electrocardiograms, and clinical records from 75 consecutive patients with CRT. RV systolic pressure was calculated from the peak tricuspid regurgitant, time-velocity profile. The primary end point was a composite of mortality, cardiac transplantation, or need for a left ventricular assist device. Events were evaluated by Kaplan-Meier curves and Cox proportional hazard ratios. Patients grouped by RV systolic pressure divided at the median of 35 mm Hg were similar except for more renal insufficiency and RV dysfunction when RV systolic pressure was >35 mm Hg. Univariate analysis identified RV systolic pressure >35 mm Hg (hazard ratio [HR] 3.32), diabetes (HR 2.45), renal insufficiency (HR 3.52), atrial fibrillation (HR 3.07), use of nonamiodarone antiarrhythmic medications (HR 2.86), atrial pacing (HR 2.57), and prolonged PR interval (HR 1.009) as associated with poorer outcome. Normal sinus rhythm at implantation (HR 0.34), baseline left bundle branch block (HR 0.44), and beta-blocker use (HR 0.47) were associated with improved outcome. In a multivariable model, high RV systolic pressure (HR 3.71, 95% confidence interval 1.31 to 10.4), renal insufficiency (HR 3.18, 95% confidence interval 1.29 to 7.86), and atrial fibrillation (HR 4.22, 95% confidence interval 1.54 to 11.6) remained significant. In conclusion, despite resynchronization, patients with high RV pressures have significantly decreased survival after adjusting for significant contributing influences.

摘要

右侧心脏压力升高对心脏再同步治疗(CRT)结局的影响程度尚不清楚。高右心室(RV)压力可能导致室间隔位置异常,从而阻碍有效的再同步。我们假设,CRT植入前右心室收缩压高的患者结局较差。我们评估了75例连续接受CRT治疗患者的超声心动图、心电图和临床记录。右心室收缩压根据三尖瓣反流峰值、时间-速度曲线计算得出。主要终点是死亡、心脏移植或需要左心室辅助装置的复合终点。通过Kaplan-Meier曲线和Cox比例风险比评估事件。按右心室收缩压在35 mmHg中位数处进行分组的患者,除右心室收缩压>35 mmHg时肾功能不全和右心室功能障碍更多外,其他情况相似。单因素分析确定,右心室收缩压>35 mmHg(风险比[HR] 3.32)、糖尿病(HR 2.45)、肾功能不全(HR 3.52)、心房颤动(HR 3.07)、使用非胺碘酮抗心律失常药物(HR 2.86)、心房起搏(HR 2.57)和PR间期延长(HR 1.009)与较差的结局相关。植入时窦性心律正常(HR 0.34)、基线左束支传导阻滞(HR 0.44)和使用β受体阻滞剂(HR 0.47)与较好的结局相关。在多变量模型中,高右心室收缩压(HR 3.71,95%置信区间1.31至10.4)、肾功能不全(HR 3.18,95%置信区间1.29至7.86)和心房颤动(HR 4.22,95%置信区间1.54至11.6)仍然具有显著性。总之,尽管进行了再同步治疗,但在调整显著的影响因素后,右心室压力高的患者生存率显著降低。

相似文献

1
Relation of right ventricular peak systolic pressure to major adverse events in patients undergoing cardiac resynchronization therapy.心脏再同步治疗患者右心室收缩压峰值与主要不良事件的关系。
Am J Cardiol. 2006 Jun 15;97(12):1737-40. doi: 10.1016/j.amjcard.2006.01.033. Epub 2006 Apr 24.
2
Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.糖尿病对晚期心力衰竭患者接受或未接受除颤器的心脏再同步治疗的影响。
J Card Fail. 2007 Nov;13(9):769-73. doi: 10.1016/j.cardfail.2007.06.723.
3
Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure.心力衰竭患者从右心室起搏升级为心脏再同步治疗的长期效果。
Europace. 2009 Apr;11(4):495-501. doi: 10.1093/europace/eup037.
4
Right atrial pacing and the risk of postimplant atrial fibrillation in cardiac resynchronization therapy recipients.心脏再同步治疗患者的右心房起搏与植入后房颤风险
Am Heart J. 2008 Jan;155(1):94-9. doi: 10.1016/j.ahj.2007.08.030. Epub 2007 Oct 25.
5
Short-term effects of right-left heart sequential cardiac resynchronization in patients with heart failure, chronic atrial fibrillation, and atrioventricular nodal block.左右心序贯心脏再同步化治疗对心力衰竭、慢性心房颤动和房室传导阻滞患者的短期影响。
Circulation. 2004 Nov 30;110(22):3404-10. doi: 10.1161/01.CIR.0000148177.82319.C7. Epub 2004 Nov 22.
6
New-onset heart failure after permanent right ventricular apical pacing in patients with acquired high-grade atrioventricular block and normal left ventricular function.获得性高度房室传导阻滞且左心室功能正常的患者在永久性右心室心尖部起搏后新发心力衰竭
J Cardiovasc Electrophysiol. 2008 Feb;19(2):136-41. doi: 10.1111/j.1540-8167.2007.01014.x. Epub 2007 Nov 12.
7
Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial.收缩性心力衰竭和左心室不同步患者泵衰竭和心源性猝死死亡率的预测因素:CARE-HF试验结果
J Card Fail. 2008 Oct;14(8):670-5. doi: 10.1016/j.cardfail.2008.06.001. Epub 2008 Jul 15.
8
Avoidance of right ventricular pacing in cardiac resynchronization therapy improves right ventricular hemodynamics in heart failure patients.在心脏再同步治疗中避免右心室起搏可改善心力衰竭患者的右心室血流动力学。
J Cardiovasc Electrophysiol. 2007 May;18(5):497-504. doi: 10.1111/j.1540-8167.2007.00788.x. Epub 2007 Apr 11.
9
Relationship of baseline electrocardiographic characteristics with the response to cardiac resynchronization therapy for heart failure.
Pacing Clin Electrophysiol. 2004 Nov;27(11):1513-8. doi: 10.1111/j.1540-8159.2004.00669.x.
10
Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.根据基线变量及早期反应预测心脏再同步治疗对死亡率的长期影响——来自CARE-HF(心力衰竭心脏再同步治疗)试验的报告
J Am Coll Cardiol. 2008 Aug 5;52(6):438-45. doi: 10.1016/j.jacc.2008.04.036.

引用本文的文献

1
Relationship of soluble ST2 to pulmonary hypertension severity in patients undergoing cardiac resynchronization therapy.心脏再同步治疗患者中可溶性ST2与肺动脉高压严重程度的关系。
J Thorac Dis. 2019 Dec;11(12):5362-5371. doi: 10.21037/jtd.2019.11.66.
2
Current role of echocardiography in cardiac resynchronization therapy.超声心动图在心脏再同步治疗中的作用。
Heart Fail Rev. 2017 Nov;22(6):699-722. doi: 10.1007/s10741-017-9636-1.
3
First-degree AV block-an entirely benign finding or a potentially curable cause of cardiac disease?
一度房室传导阻滞——完全良性的表现还是潜在可治愈的心脏病病因?
Ann Noninvasive Electrocardiol. 2013 May;18(3):215-24. doi: 10.1111/anec.12062.
4
Subharmonic microbubble emissions for noninvasively tracking right ventricular pressures.亚谐波微泡发射可无创追踪右心室压力。
Am J Physiol Heart Circ Physiol. 2012 Jul;303(1):H126-32. doi: 10.1152/ajpheart.00560.2011. Epub 2012 May 4.
5
Prognostic effects of pulmonary hypertension in patients undergoing cardiac resynchronization therapy.肺动脉高压对接受心脏再同步治疗患者的预后影响。
J Thorac Dis. 2010 Jun;2(2):71-5.
6
Right ventricular dysfunction is a predictor of non-response and clinical outcome following cardiac resynchronization therapy.右心室功能障碍是心脏再同步治疗后无反应和临床结局的预测因子。
J Cardiovasc Magn Reson. 2011 Oct 31;13(1):68. doi: 10.1186/1532-429X-13-68.
7
Informed consent in cardiac resynchronization therapy: what should be said?心脏再同步治疗中的知情同意:应该告知哪些内容?
Circ Cardiovasc Qual Outcomes. 2011 Sep;4(5):573-7. doi: 10.1161/CIRCOUTCOMES.111.961680.
8
Cardiac resynchronization therapy in the cardiorenal syndrome.心肾综合征中的心脏再同步治疗
Int J Nephrol. 2011;2011:168461. doi: 10.4061/2011/168461. Epub 2011 Jun 9.
9
First-degree atrioventricular block. Clinical manifestations, indications for pacing, pacemaker management & consequences during cardiac resynchronization.一度房室传导阻滞。临床表现、起搏指征、起搏器管理及心脏再同步化治疗期间的后果。
J Interv Card Electrophysiol. 2006 Nov;17(2):139-52. doi: 10.1007/s10840-006-9065-x. Epub 2007 Mar 2.